Iran J Reprod Med. 2014 Oct;12(10):681-6.
Altered of microRNA expression level in oligospermic patients.
Iranian journal of reproductive medicine
Alireza Abhari, Nosratollah Zarghami, Laya Farzadi, Mohammad Nouri, Vahideh Shahnazi
Affiliations
Affiliations
- Department. of Biochemistry and Clinical Laboratories, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.
- Women's Reproductive Health Research Center, Al-zahra Hospital, Tabriz University of Medical Sciences, Tabriz, Iran .
PMID: 25469126
PMCID: PMC4248154
Abstract
BACKGROUND: MicroRNA (miRNA) is small endogenous, single strand RNA molecules that regulate gene expression at post-transcriptional level through several mechanisms to affect key cellular event including male germ cells differentiation, proliferation, development and apoptosis. Mutation and/or aberrant expression of miRNAs have been associated with progression of various disorders, including infertility.
OBJECTIVE: The purpose of this research was to study the estrogen receptor beta (ERβ(, hsa-mir-21 and, hsa-mir-22 expression level in oligospermic infertile and control fertile men and correlation between them.
MATERIALS AND METHODS: In this study, the change in mir-21, mir-22 expression and their common target gene (ERβ) expression levels were evaluated in oligospermic infertile men (n= 43) compared with 43 age matched healthy control by Real-Time PCR methods.
RESULTS: Expression analysis by qRT-PCR test on miRNA have identified that mir-21, mir-22 levels were significantly higher than those in normal controls (p<0.0001) and ERβ expression level significantly decreased in comparison with the normal group (p<0.0001).
CONCLUSION: Our study showed that mir-21 and mir-22 are indirectly involved in spermatogenesis by regulating of the estrogen receptor and might have a diagnostic and prognostic value in men infertility.
Keywords: Fertility; Oligospermia; microRNA; mir-21; mir-22
References
- Nat Rev Mol Cell Biol. 2010 Apr;11(4):252-63 - PubMed
- Cell Mol Life Sci. 2009 Aug;66(15):2405-26 - PubMed
- Mol Cell Biochem. 2011 Nov;357(1-2):31-8 - PubMed
- Int J Oncol. 2013 Jan;42(1):219-28 - PubMed
- Dev Growth Differ. 2004 Oct;46(5):459-70 - PubMed
- Semin Cell Dev Biol. 1998 Aug;9(4):411-6 - PubMed
- Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2257-61 - PubMed
- Asian J Androl. 2010 Jan;12(1):47-58 - PubMed
- Steroids. 2010 Dec;75(12):998-1004 - PubMed
- Nucleic Acids Res. 2009 Aug;37(14):4850-61 - PubMed
- Endocrinology. 1996 Nov;137(11):4796-805 - PubMed
- J Androl. 2005 Jan-Feb;26(1):70-4 - PubMed
- Reprod Sci. 2012 Jan;19(1):31-42 - PubMed
- Environ Health Perspect. 2000 Oct;108(10):961-6 - PubMed
- Folia Histochem Cytobiol. 2007;45 Suppl 1:S5-10 - PubMed
- Reproduction. 2006 Sep;132(3):477-84 - PubMed
- Nucleic Acids Res. 2001 May 1;29(9):e45 - PubMed
- Arch Androl. 1992 Jan-Feb;28(1):15-7 - PubMed
- Reprod Biol Endocrinol. 2009 Feb 11;7:13 - PubMed
- Am J Clin Pathol. 2011 Aug;136(2):247-51 - PubMed
- Hum Mol Genet. 2000 Sep 1;9(14):2183-7 - PubMed
- Int J Androl. 2010 Aug 1;33(4):642-9 - PubMed
- Reprod Domest Anim. 2012 Oct;47(5):782-90 - PubMed
- J Mol Med (Berl). 2009 Jul;87(7):735-48 - PubMed
- Arch Androl. 2007 May-Jun;53(3):161-7 - PubMed
- Mol Cell Endocrinol. 2013 Sep 5;377(1-2):33-43 - PubMed
- Acta Eur Fertil. 1992 May-Jun;23(3):117-21 - PubMed
- Biol Reprod. 2008 Jan;78(1):101-14 - PubMed
- Front Biosci (Schol Ed). 2012 Jun 01;4:1266-74 - PubMed
- Reprod Biomed Online. 2011 Feb;22(2):103-5 - PubMed
- Toxicol In Vitro. 2010 Jun;24(4):1168-75 - PubMed
- J Androl. 2012 May-Jun;33(3):309-37 - PubMed
- PLoS One. 2012;7(4):e35553 - PubMed
- Biol Reprod. 2006 Dec;75(6):877-84 - PubMed
Publication Types